Guardian Pharmacy Services (NYSE:GRDN) Announces Quarterly Earnings Results

Guardian Pharmacy Services (NYSE:GRDN) announced its quarterly earnings results on Tuesday. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19), Zacks reports. The business had revenue of $314.39 million for the quarter, compared to the consensus estimate of $303.21 million. Guardian Pharmacy Services updated its FY 2024 guidance to EPS.

Guardian Pharmacy Services Stock Performance

Shares of Guardian Pharmacy Services stock traded up $0.79 during trading on Friday, hitting $21.79. The stock had a trading volume of 15,178 shares, compared to its average volume of 155,530. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $23.05.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the firm’s stock in a transaction on Friday, September 27th. The shares were purchased at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the transaction, the director now owns 35,714 shares in the company, valued at $499,996. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Analyst Ratings Changes

GRDN has been the subject of a number of recent analyst reports. Stephens started coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price objective for the company. Raymond James began coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 price target on the stock. Finally, Truist Financial upped their price objective on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Friday.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.